Weiss’s leadership in digital-first, tech-enabled marketing innovation will be pivotal as MERGE continues to pioneer the blending of sophisticated digital platforms with client-focused services.
Cranwell is a highly seasoned and self-motivated marketing professional, bringing over 2 decades of experience in healthcare marketing, with an emphasis on life-altering diseases, including oncology and rare diseases. Her focus on strategic planning, business development, and team building will play a pivotal role in Wedgewood’s continued success.
The FDA’s approval of Kisqali in combination with an aromatase inhibitor allows Novartis to target patients with earlier breast cancer who are at risk of recurrence.
The mesothelioma approval for the Keytruda combination regimen potentially unlocks a $12 billion market opportunity, according to a recent report from research firm IMARC Group.
The public-private alliance which co-funds vaccine purchases for low-income countries, said it will spend up to $50 million on the plan, which includes the transportation, delivery and costs of administering the vaccines.
Founded in 1999, Sam Brown Inc. is a full-service, independent healthcare communications agency that provides strategic communications services to a wide range of biotechnology, pharmaceutical and venture capital companies whose cutting-edge science and innovation span all phases of the life science continuum – from launch and discovery research through late-stage clinical development to product launches and commercialization.